[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-studies-list:{\"overallStatus\":[\"RECRUITING\",\"AVAILABLE\",\"NOT_YET_RECRUITING\"],\"leadSponsorName\":\"MOVMEDIX\",\"orderBy\":\"LastUpdateSubmitDate:desc\",\"size\":25,\"offset\":0}":3,"health-study-condition:":39},{"pageToken":4,"total":5,"offset":6,"count":5,"results":7},null,1,0,[8],{"id":9,"slug":10,"hasResults":11,"nctId":12,"briefTitle":13,"officialTitle":13,"acronym":4,"eligibilityCriteria":14,"healthyVolunteers":11,"sex":15,"minAge":16,"maxAge":4,"enrollmentInfo":17,"targetDuration":4,"studyType":20,"phases":4,"briefSummary":21,"conditions":22,"keywords":24,"overallStatus":27,"whyStopped":4,"lastUpdateSubmitDate":28,"lastUpdatePostDateStruct":29,"startDateStruct":32,"completionDateStruct":34,"leadSponsor":36,"locationsCount":4},"100659353","post-market-clinical-follow-up-of-lars-ligaments-associated-to-fixations-in-acute-or-chronic-injury-of-the-anterior-cruciate-ligament-acl-posterior-cruciate-pcl-or-medial-collateral-mcl-ligaments-of-the-knee-100659353",false,"NCT07864337","Post Market Clinical Follow-up of LARS® Ligaments Associated to Fixations in Acute or Chronic Injury of the Anterior Cruciate Ligament (ACL), Posterior Cruciate (PCL) or Medial Collateral (MCL) Ligaments of the Knee","Inclusion Criteria:\n\n1. Patient who received study information and provided informed consent to participate in the study, where required by applicable local regulations and ethics committee requirements.\n2. Patient who underwent ligamentoplasty using one or more LARS® artificial ligaments for posterior cruciate ligament (PCL), anterior cruciate ligament (ACL), and\u002For medial collateral ligament (MCL) in only 1 leg (knee) reconstruction between 2015 and 2018 (or since 9 to 12 years from data collection time-point).\n3. Surgical procedure performed using LARS® ligaments in accordance with the intended use and routine clinical practice.\n4. Availability of adequate medical records and follow-up documentation allowing assessment of the study endpoints related to safety and performance\n\nExclusion Criteria:\n\n1. Patients aged less than 18 years at the time of the ligamentoplasty procedure.\n2. Patients presenting, at the date of surgery, with any contraindication to ligamentoplasty procedures and\u002For contraindications specified in the applicable Instructions for Use (IFU) of the implanted device.\n3. Patients who are lost to follow-up, deceased at the time of study conduct.\n4. Patients who have undergone bilateral ligamentoplasty.\n5. Patients belonging to a protected or vulnerable population, including individuals under guardianship, curatorship, legal protection measures, or any other condition limiting their ability to provide informed consent in accordance with applicable local regulations.\n6. Patients for whom the implanted ligament and\u002For associated fixation devices cannot be reliably identified from the available documentation.","ALL","18 Years",{"count":18,"type":19},257,"ESTIMATED","OBSERVATIONAL","This study aims to assess the long-term safety, stability, knee function, pain, and satisfaction of patients who received a LARS® ligament to treat an injury of one of the main ligaments of the knee.",[23],"Knee Ligament Injury",[25,26],"LARS® ligament","Artificial knee ligament","NOT_YET_RECRUITING","2026-10-02",{"date":30,"type":31},"2026-10-07","ACTUAL",{"date":33,"type":19},"2026-12",{"date":35,"type":19},"2028-12",{"name":37,"class":38},"MOVMEDIX","INDUSTRY",""]